CCM
BMY icon

Cadian Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Cadian Capital Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-275,000
Closed -$14.3M – 80
2014
Q1 		$14.3M Buy
+275,000
New +$14.6M 0.36% 50

Other funds holding BMY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Cadian Capital Management's BMY Position: Q2 2014 in Review

Cadian Capital Management sold out of Bristol-Myers Squibb (BMY) in Q2 2014, closing a stake of 275,000 shares — an estimated $14.3M sold.

Cadian Capital Management first reported a position in BMY in Q1 2014 and held it in 1 quarter. The position peaked at $14.3M in Q1 2014. 1,302 funds tracked by Wall St. Rank hold BMY as of Q2 2014.

  • Cadian Capital Management reported no remaining Bristol-Myers Squibb position as of Q2 2014 after selling out during the quarter.
  • Cadian Capital Management sold 275,000 Bristol-Myers Squibb shares in Q2 2014, an estimated $14.3M.
  • Cadian Capital Management first reported a position in Bristol-Myers Squibb in Q1 2014 and held it in 1 quarter.
  • Cadian Capital Management's Bristol-Myers Squibb position peaked at $14.3M in Q1 2014.
  • 1,302 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2014.

Based on Cadian Capital Management's 13F filing for Q2 2014, filed 13 Aug 2014.